Our initial focus is on infectious disease testing

Our first two products will detect influenza A/B virus and chlamydia/gonorrhea bacteria from nasal swabs and genital swabs, respectively. They are being developed for at-home use by consumers and point-of-care use by healthcare professionals. Data from large clinical studies indicates these products will have comparable accuracy to FDA-cleared, lab-based methods. The components of our swab-based infectious disease testing platform are shown below.